AI Article Synopsis

  • This meta-analysis investigates the potential of TWEAK as a diagnostic biomarker for lupus nephritis (LN), showing that it is elevated in patients with the condition.
  • The analysis included data from nine studies and found that TWEAK has a sensitivity of 0.69 and specificity of 0.77 for identifying active LN.
  • The study suggests TWEAK could be a promising biomarker, but more research is needed to confirm its diagnostic effectiveness and determine specific cutoff values for active LN.

Article Abstract

Purpose: Accumulative studies showed that tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) was up-regulated in the blood and urine from patients diagnosed with lupus nephritis (LN) and that it might be used as a novel biomarker for active LN. This meta-analysis aimed to determine the diagnostic value of TWEAK in active LN.

Methods: We searched the Cochrane Library, Embase, PubMed, Springer, Wanfang and CNKI databases for articles published up to 20 August 2020. The diagnostic capacity of TWEAK for active LN was assessed using pooled sensitivity and specificity, positive and negative likelihood ratios (PLR and NLR), diagnostic odds ratio (DOR), and area under the receiver operating characteristic curve (AUC). Quality assessment and publication bias were also evaluated. STATA 11.0 and Meta-Disc 1.4 were used to perform these analyses.

Results: Nine cross-sectional studies were included in this meta-analysis. The overall pooled sensitivity of TWEAK for the diagnosis of active LN was 0.69 (95% CI, 0.63-0.75), and specificity was 0.77 (95% CI, 0.71-0.82). The overall pooled PLR and NLR were 3.31 (95% CI, 2.05-5.35) and 0.38 (95% CI, 0.26-0.55), respectively, with a DOR of 10.89 (95% CI, 6.73-17.63) and AUC (SE) of 0.8276 (0.0289). Deeks' funnel plot revealed that the publication bias was insignificant in the study ( = .32).

Conclusions: Our results suggest that TWEAK might be a potential biomarker for patients with active LN. Future cross-sectional and longitudinal studies are needed to confirm its diagnostic value, as well as to establish more definite cutoff for active LN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745842PMC
http://dx.doi.org/10.1080/0886022X.2020.1853568DOI Listing

Publication Analysis

Top Keywords

diagnostic tweak
8
lupus nephritis
8
tweak active
8
pooled sensitivity
8
plr nlr
8
publication bias
8
active
7
diagnostic
5
tweak
5
95%
5

Similar Publications

Key Clinical Message: The coexistence of rheumatoid arthritis (RA) and PLA2R-associated membranous nephropathy (MN) is uncommon. It is difficult to demonstrate whether the mechanisms of renal pathology are triggered by RA, but it has been observed that the pro-inflammatory molecules present in RA increase the expression of PLA2R. Rituximab could be effective in both conditions.

View Article and Find Full Text PDF

Self-supervised learning on dual-sequence magnetic resonance imaging for automatic segmentation of nasopharyngeal carcinoma.

Comput Med Imaging Graph

December 2024

Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen, China; Shenzhen University Medical School, Shenzhen University, Shenzhen, 518055, Guangdong, China. Electronic address:

Article Synopsis
  • Automating the segmentation of nasopharyngeal carcinoma (NPC) improves treatment processes, but challenges arise from the lack of large annotated datasets.
  • The study leverages self-supervised learning combined with a saliency transformation module using unlabeled dual-sequence MRI to enhance segmentation accuracy, achieving a Dice similarity coefficient of 0.77 with a limited number of labeled cases.
  • This method not only reduces the annotation workload for oncologists, making the process more efficient and objective, but also ensures reliable identification of NPC.
View Article and Find Full Text PDF

Background: Atherosclerosis is increased in patients with rheumatoid arthritis (RA) and early diagnosis of vascular disease leads to better outcome. Our aim was to evaluate whether aortic elasticity decreases in the subclinical stage of atherosclerosis in RA patients without any cardiovascular disease and to determine disease-related risk factors.

Methods: One hundred fourteen patients with RA, 50 patients with spondyloarthritis, and 50 healthy control were included in this study.

View Article and Find Full Text PDF

Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP.

Viral Immunol

November 2024

Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), the main neurological manifestation of HTLV-I, is a chronic inflammatory disease. Viral-host interaction and host genetics are two important contributors to the development of the HAM/TSP. This study was conducted to measure the serum level of tumor necrosis factor-alpha-like weak inducer of apoptosis (TWEAK) by ELISA method in three groups of participants including 34 HAM/TSP patients (HAM/TSP), 35 asymptomatic HTLV-1 carriers (ACs), and 20 healthy controls (HCs).

View Article and Find Full Text PDF
Article Synopsis
  • - Fetal Alcohol Spectrum Disorders (FASD) refers to a variety of conditions caused by drinking alcohol during pregnancy, impacting the central nervous system, growth, and facial features.
  • - Early screening for FASD is critical since there are no treatments; methods include assessing alcohol biomarkers in maternal blood and meconium, as well as using sensitive questionnaires to identify at-risk pregnancies.
  • - The review emphasizes the importance of combining alcohol biomarkers with traditional screening tools to ensure more accurate detection and monitoring of alcohol consumption during pregnancy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!